1[1]Roilides E,Butler KM,Husson RN,et al.Pseudomonas infection in children with human immunodeficiency virus infection[J].Pediatr Infect Dis,1992,11(7):547.
2[2]Marty N,Dournes JL,Chabanon G,et al.Influence of nutrient media on the chemical composition of the exopolysaccharide from mucoid and non-mucoid Pseudomonas aeruginosa[J].FEMS Microbiol lett,1992,77 (1-3):35.
3[3]Marty N,Pasquier C,Dournes JL,et al.Effects of characterized Pseudomonas aeruginosa exopolysacharides on adherence to human tracheal cells[J].J Med Microbiol,1998,47(2):129.
4[4]Meluleni GJ,Grout M,Evans DJ,et al.Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by antibodies produced during chronic lung infection in cystic fibrosis[J].J Immunol,1995,155(4):2029.
5[5]Feavers IM,Suker J,Mckenna AJ,et al.Molecular analysis of the serotyping antigen of Neisseria Meningitidis[J].Infect Immun,1992,60 (9):3620.
6[6]Hatano K,Boisot S,DesJardins D,et al.Immunogenic and antigenic properties of a hepavalent high-molecular-weight o-polysaccharide vaccine derived from Pseudomonas aeruginosa[J].Infect Immun,1994,62 (9):3608.
7[7]Staczek J,Gilleland HE Jr,Gilleland LB,et al.A chimeric influenza virus expressing an epitope of outermembrane protein F of Pseudomonas aeruginosa affords protection against challenge with P.aeruginosa in a murine model of chronic pulmonary infection[J].Infect Immun,1998,66(8):3990.
8[8]Matsumoto T,Tateda K,Furuya N,et al.Efficacies of alkaline protease、elastase and exotoxin A toxoid vaccine against gut-derived Pseudomonas aeruginosa sepsis in mice[J].J Med Microbiol,1998,47(4):303.
9[9]Pier GB,Small GJ,Warren HB.Protection against mucoid Pseudomonas aeruginosa in rodent model of endobronchial infection[J].Science,1990,249(4968):537.
